Oncolytic Viruses Get a Boost With First FDA-approval Recommendation

Nature Reviews Drug Discovery - United Kingdom
doi 10.1038/nrd4680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Micromanaging Oncolytic Viruses

Science-Business eXchange
2008English

First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval

Clinical Cancer Research
Cancer ResearchOncology
2018English

Obinutuzumab Breaks Through to FDA Approval

Cancer Discovery
Oncology
2013English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Cancer-Fighting Viruses Win Approval

Nature
Multidisciplinary
2015English

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Oncolytic Viruses: Overcoming Translational Challenges

Journal of Clinical Investigation
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy